PCAR vs PMCB · P/E 25, rev $33.66B vs $8.6M cap
PACCAR Inc (PCAR) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Latest reported PMCB revenue for 2026-04-30 was $0. Net income was -$19.4M. PMCB currently screens at market cap $8.6M.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the PCAR and PMCB stock pages for the full models.
Not investment advice.